Obesity and brain structure in schizophrenia - ENIGMA study in 3021 individuals.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
09 2022
Historique:
received: 17 12 2021
accepted: 06 05 2022
revised: 27 04 2022
pubmed: 24 6 2022
medline: 2 12 2022
entrez: 23 6 2022
Statut: ppublish

Résumé

Schizophrenia is frequently associated with obesity, which is linked with neurostructural alterations. Yet, we do not understand how the brain correlates of obesity map onto the brain changes in schizophrenia. We obtained MRI-derived brain cortical and subcortical measures and body mass index (BMI) from 1260 individuals with schizophrenia and 1761 controls from 12 independent research sites within the ENIGMA-Schizophrenia Working Group. We jointly modeled the statistical effects of schizophrenia and BMI using mixed effects. BMI was additively associated with structure of many of the same brain regions as schizophrenia, but the cortical and subcortical alterations in schizophrenia were more widespread and pronounced. Both BMI and schizophrenia were primarily associated with changes in cortical thickness, with fewer correlates in surface area. While, BMI was negatively associated with cortical thickness, the significant associations between BMI and surface area or subcortical volumes were positive. Lastly, the brain correlates of obesity were replicated among large studies and closely resembled neurostructural changes in major depressive disorders. We confirmed widespread associations between BMI and brain structure in individuals with schizophrenia. People with both obesity and schizophrenia showed more pronounced brain alterations than people with only one of these conditions. Obesity appears to be a relevant factor which could account for heterogeneity of brain imaging findings and for differences in brain imaging outcomes among people with schizophrenia.

Identifiants

pubmed: 35739320
doi: 10.1038/s41380-022-01616-5
pii: 10.1038/s41380-022-01616-5
pmc: PMC9902274
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3731-3737

Subventions

Organisme : NIMH NIH HHS
ID : R01 MH118695
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH116147
Pays : United States
Organisme : Wellcome Trust
ID : 103703
Pays : United Kingdom
Organisme : CIHR
ID : 106469
Pays : Canada
Organisme : CIHR
ID : 142255
Pays : Canada

Commentaires et corrections

Type : ErratumIn
Type : ErratumIn

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Br J Psychiatry. 2010 Feb;196(2):116-21
pubmed: 20118455
Eur Heart J. 2019 Jul 21;40(28):2290-2300
pubmed: 30854560
Hum Brain Mapp. 2015 Jun;36(6):2330-7
pubmed: 25704752
Neuropsychopharmacology. 2014 Nov;39(12):2910-8
pubmed: 25074491
Neuroimage Clin. 2017 Dec 20;17:899-909
pubmed: 29527494
PLoS One. 2018 Oct 18;13(10):e0205331
pubmed: 30335775
World Psychiatry. 2015 Oct;14(3):339-47
pubmed: 26407790
Appetite. 2015 Apr;87:56-61
pubmed: 25526826
Int J Obes (Lond). 2016 Jul;40(7):1177-82
pubmed: 27089992
Acta Psychiatr Scand. 2018 Dec;138(6):581-590
pubmed: 30264457
Neuroscience. 2013 Nov 12;252:109-17
pubmed: 23933215
Arch Gen Psychiatry. 2007 Oct;64(10):1123-31
pubmed: 17909124
Lancet Psychiatry. 2019 Aug;6(8):675-712
pubmed: 31324560
J Am Soc Nephrol. 2004 Nov;15(11):2792-800
pubmed: 15504932
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Obesity (Silver Spring). 2008 Jan;16(1):119-24
pubmed: 18223623
Bipolar Disord. 2020 Aug;22(5):440-460
pubmed: 32356562
Neuroimage. 2019 Oct 1;199:261-272
pubmed: 31163268
Neuroreport. 2003 Oct 6;14(14):1829-32
pubmed: 14534429
Physiol Behav. 2014 Sep;136:121-7
pubmed: 24769220
Int J Obes (Lond). 2013 Nov;37(11):1435-42
pubmed: 23459322
J Psychiatr Res. 2018 Apr;99:151-158
pubmed: 29454222
J Psychiatr Res. 2020 Nov;130:137-151
pubmed: 32818662
J Clin Neurosci. 2020 Mar;73:280-287
pubmed: 31992512
Nature. 2006 Dec 14;444(7121):875-80
pubmed: 17167476
JAMA Psychiatry. 2015 Apr;72(4):305-15
pubmed: 25651064
Mol Psychiatry. 2018 Apr;23(4):932-942
pubmed: 28461699
Int J Geriatr Psychiatry. 2020 Jul;35(7):728-736
pubmed: 32128879
J Neuroinflammation. 2016 Mar 24;13(1):67
pubmed: 27012931
Schizophr Bull. 2017 May 1;43(3):601-610
pubmed: 27559077
Psychiatry Res Neuroimaging. 2020 Aug 30;302:111100
pubmed: 32464535
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Metab Brain Dis. 2018 Aug;33(4):1211-1222
pubmed: 29654499
Hum Brain Mapp. 2010 Mar;31(3):353-64
pubmed: 19662657
Int J Obes (Lond). 2019 May;43(5):943-951
pubmed: 30022057
Neurology. 2019 Feb 5;92(6):e594-e600
pubmed: 30626649
JAMA Netw Open. 2019 Dec 2;2(12):e1917257
pubmed: 31825506
JAMA Pediatr. 2020 Feb 1;174(2):170-177
pubmed: 31816020
Schizophr Bull. 2013 Mar;39(2):295-305
pubmed: 22927670
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Curr Opin Psychiatry. 2016 Jan;29(1):1-6
pubmed: 26575297
Mol Psychiatry. 2021 Nov;26(11):6806-6819
pubmed: 33863996
Addict Biol. 2021 May;26(3):e12974
pubmed: 33084195
Am J Clin Nutr. 2011 Jun;93(6):1190-5
pubmed: 21450935
Neuroimage. 2015 Nov 15;122:149-57
pubmed: 26256530
Neurosci Biobehav Rev. 2019 Mar;98:85-94
pubmed: 30615934
Schizophr Res. 2008 Jul;102(1-3):171-80
pubmed: 18248959
Bipolar Disord. 2009 Sep;11(6):650-6
pubmed: 19689507
Acta Psychiatr Scand. 2006 Apr;113(4):306-13
pubmed: 16638075
Biol Psychiatry. 2020 Nov 1;88(9):678-686
pubmed: 32646651
Mol Psychiatry. 2021 Sep;26(9):4839-4852
pubmed: 32467648
Aust N Z J Psychiatry. 2019 Dec;53(12):1179-1188
pubmed: 31244332
JAMA Psychiatry. 2017 Nov 1;74(11):1104-1111
pubmed: 28973084
Schizophr Bull. 2021 Oct 21;47(6):1772-1781
pubmed: 34080013
Radiology. 2019 Jun;291(3):763-771
pubmed: 31012815
Schizophr Bull. 2013 Mar;39(2):306-18
pubmed: 22207632
Mol Psychiatry. 2016 Dec;21(12):1710-1716
pubmed: 26857596
Ageing Res Rev. 2015 Mar;20:86-97
pubmed: 24768742
Psychol Med. 2017 Apr;47(6):1030-1040
pubmed: 28032535
Biol Psychiatry. 2018 Nov 1;84(9):644-654
pubmed: 29960671
Behav Neurosci. 2010 Dec;124(6):742-60
pubmed: 21133531
Transl Psychiatry. 2020 Mar 20;10(1):100
pubmed: 32198361
Front Psychiatry. 2020 Sep 23;11:556759
pubmed: 33173508

Auteurs

Sean R McWhinney (SR)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Katharina Brosch (K)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Vince D Calhoun (VD)

Tri-institutional Center for Translational Research in Neuroimaging and Data Science (TReNDS), Georgia State, Georgia Tech, Emory University, Atlanta, GA, USA.

Benedicto Crespo-Facorro (B)

Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
IBiS, University Hospital Virgen del Rocio, Sevilla, Spain.
Department of Psychiatry, School of Medicine, University of Sevilla, Sevilla, Spain.

Nicolas A Crossley (NA)

Department of Psychiatry, School of Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Department of Psychosis Studies, King's College London, London, UK.

Udo Dannlowski (U)

Institute for Translational Psychiatry, University of Münster, Münster, Germany.

Erin Dickie (E)

Centre for Addiction & Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Lorielle M F Dietze (LMF)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Gary Donohoe (G)

Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.

Stefan Du Plessis (S)

Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
SAMRC Genomics of Brain Disorders Unit, Cape Town, South Africa.

Stefan Ehrlich (S)

Translational Developmental Neuroscience Section, Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany.

Robin Emsley (R)

Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Petra Furstova (P)

National Institute of Mental Health, Klecany, Czech Republic.

David C Glahn (DC)

Department of Psychiatry & Behavioral Sciences, Boston Children's Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.
Olin Neuropsychiatry Research Center, Institute of Living, Hartford, CT, USA.

Alfonso Gonzalez-Valderrama (A)

School of Medicine, Universidad Finis Terrae, Santiago, Chile.
Early Intervention in Psychosis Program, Instituto Psiquiátrico 'Dr. José Horwitz B.', Santiago, Chile.

Dominik Grotegerd (D)

Institute for Translational Psychiatry, University of Münster, Münster, Germany.

Laurena Holleran (L)

Centre for Neuroimaging & Cognitive Genomics (NICOG), Clinical Neuroimaging Laboratory, NCBES Galway Neuroscience Centre, College of Medicine Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland.

Tilo T J Kircher (TTJ)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Pavel Knytl (P)

National Institute of Mental Health, Klecany, Czech Republic.
Charles University, Third Faculty of Medicine, Prague, Czech Republic.

Marian Kolenic (M)

National Institute of Mental Health, Klecany, Czech Republic.
Charles University, Third Faculty of Medicine, Prague, Czech Republic.

Rebekka Lencer (R)

Institute for Translational Psychiatry, University of Münster, Münster, Germany.
Department of Pscyhiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.

Igor Nenadić (I)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Nils Opel (N)

Institute for Translational Psychiatry, University of Münster, Münster, Germany.
Department of Psychiatry, Jena University Hospital/Friedrich-Schiller-University Jena, Jena, Germany.

Julia-Katharina Pfarr (JK)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Amanda L Rodrigue (AL)

Department of Psychiatry & Behavioral Sciences, Boston Children's Hospital, Boston, MA, USA.
Department of Psychiatry, Harvard Medical School, Boston, MA, USA.

Kelly Rootes-Murdy (K)

Department of Psychology, Georgia State University, Atlanta, GA, USA.

Alex J Ross (AJ)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.

Kang Sim (K)

West Region, Institute of Mental Health, Singapore, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.

Antonín Škoch (A)

National Institute of Mental Health, Klecany, Czech Republic.
Department of Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.

Filip Spaniel (F)

National Institute of Mental Health, Klecany, Czech Republic.
Charles University, Third Faculty of Medicine, Prague, Czech Republic.

Frederike Stein (F)

Department of Psychiatry and Psychotherapy, Philipps-University Marburg, Marburg, Germany.

Patrik Švancer (P)

National Institute of Mental Health, Klecany, Czech Republic.
Charles University, Third Faculty of Medicine, Prague, Czech Republic.

Diana Tordesillas-Gutiérrez (D)

Department of Radiology, Marqués de Valdecilla University Hospital, Valdecilla Biomedical Research Institute IDIVAL, Santander, Spain.
Computación Avanzada y Ciencia, Instituto de Física de Cantabria, CSIC, Santander, Spain.

Juan Undurraga (J)

Early Intervention in Psychosis Program, Instituto Psiquiátrico 'Dr. José Horwitz B.', Santiago, Chile.
Department of Neurology and Psychiatry. Faculty of Medicine, Clínica Alemana Universidad del Desarrollo, Santiago, Chile.

Javier Vázquez-Bourgon (J)

Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain.
Department of Medicine and Psychiatry, School of Medicine, University of Cantabria, Santander, Spain.
Department of Psychiatry, Marqués de Valdecilla University Hospital, Valdecilla Biomedical Research Institute IDIVAL, Santander, Spain.

Aristotle Voineskos (A)

Centre for Addiction & Mental Health, Department of Psychiatry, University of Toronto, Toronto, ON, Canada.

Esther Walton (E)

Department of Psychology, University of Bath, Bath, UK.

Thomas W Weickert (TW)

Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
Neuroscience Research Australia, Randwick, NSW, Australia.

Cynthia Shannon Weickert (CS)

Department of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
Neuroscience Research Australia, Randwick, NSW, Australia.
School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Theo G M van Erp (TGM)

Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA.
Center for the Neurobiology of Learning and Memory, University of California Irvine, Irvine, CA, USA.

Jessica A Turner (JA)

Department of Psychology, Georgia State University, Atlanta, GA, USA.

Tomas Hajek (T)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada. tomas.hajek@dal.ca.
National Institute of Mental Health, Klecany, Czech Republic. tomas.hajek@dal.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH